Evidence map›Paper›PMID 33894566›Full record

ArticleBioelectrochemistry (Amsterdam, Netherlands)2021

Delivery and expression of plasmid DNA into cells by a novel non-thermal plasma source.

Eva Dolezalova, Muhammad A Malik, Loree Heller, Richard Heller

Abstract read
In one paragraph

Article in Bioelectrochemistry (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eva DolezalovaFrank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA, USA.
Muhammad A MalikDepartment of Chemistry and Biochemistry, Hampton University, Hampton, VA, USA.
Loree HellerDepartment of Medical Engineering, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Richard HellerDepartment of Medical Engineering, Morsani College of Medicine, University of South Florida, Tampa, FL, USA. Electronic address: rheller@usf.edu.

Funding

Controlled Delivery of Plasmid DNA via Low-Temperature Ion DepositionR01EB023878 · NIBIB · UNIVERSITY OF SOUTH FLORIDA · PI HELLER, RICHARD · 2018 to 2022
$1.7M
NIBIB NIH HHS R01 EB023878
6 · The paper itself

Abstract

Medical applications such as plasma assisted gene transfer is a minimally invasive approach that can substantially reduce potential discomfort of treated area. Atmospheric pressure plasma discharge is an effective approach to deliver plasmid DNA for in vitro and in vivo applications. We investigated plasma assisted delivery in vitro in mouse melanoma cells (B16F10) using a novel surface plasma device, which is operated in air. We evaluated the influence of applied voltage and distance between the surface device and cell monolayer. We found no significant effect on the viability of cells. Highest expression following delivery of a plasmid encoding green fluorescent protein was achieved with an applied voltage of 11.25 kV at a 2 mm distance and 5 s exposure time. To better understand the influence of oxidative damages and stress on cells after plasma delivery, a mRNA expression study was performed. Our results indicated that TNFα mRNA was significantly upregulated. The mRNA response may be attributed to the RONS generated by plasma; however, this mRNA upregulation was not adequate to be reflected in a coordinate protein upregulation. From the results reported here, it is clear that this novel plasma device could be used for plasmid delivery.

Indexed as

AnimalsDNADrug Delivery SystemsGene ExpressionMelanoma, ExperimentalMicePlasmidsDNAGene transferGreen fluorescent proteinNon-thermalPlasma

Identifiers

PMID33894566
PMCPMC8187306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.